Send mail to Author

Hematologic safety of 177Lu-PSMA-617 radioligand therapy in patients with metastatic castration-resistant prostate cancer (Article)

Please indicate your contact information and select, which author you want to contact.



 
 __   _     _____    _    _     _____    ______    __   __  
| || | ||  |  ___|| | || | ||  |  ___|| |      \\  \ \\/ // 
| '--' ||  | ||__   | || | ||  | ||__   |  --  //   \ ` //  
| .--. ||  | ||__   | \\_/ ||  | ||__   |  --  \\    | ||   
|_|| |_||  |_____||  \____//   |_____|| |______//    |_||   
`-`  `-`   `-----`    `---`    `-----`  `------`     `-`'
 


Back to frontdoor view

OPUS4 Logo